Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 4/20 | 0.33 |
| ▸ | HRH1 | P35367 | 4/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.33 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30149469 | 1.00 | CYP2D6 (0.33) | CYP2D6HRH1CHRM1KCNH2AAK1 | |
| SCHEMBL28229981 | 0.79 | CCNB2 (0.36) | CYP2D6HRH1CHRM1KCNH2 | |
| SCHEMBL997911 | 0.79 | CYP2D6 (0.39) | CYP2D6HRH1CHRM1KCNH2CYP19A1 | |
| SCHEMBL674404 | 0.78 | CYP2D6 (0.38) | CYP2D6HRH1CHRM1KCNH2CYP19A1 | |
| SCHEMBL29466583 | 0.77 | TRPM8 (0.39) | CYP2D6HRH1CHRM1KCNH2 | |
| SCHEMBL113424 | 0.77 | TRPM8 (0.39) | CYP2D6HRH1CHRM1KCNH2 | |
| SCHEMBL20873451 | 0.76 | CCNB2 (0.39) | CYP2D6KCNH2GPR84 | |
| SCHEMBL2581673 | 0.75 | CYP2D6 (0.37) | CYP2D6HRH1CHRM1KCNH2 | |
| SCHEMBL28249387 | 0.73 | PDE3B (0.37) | CYP2D6HRH1CHRM1KCNH2 | |
| SCHEMBL13939867 | 0.72 | CYP11B1 (0.41) | CYP2D6HRH1CHRM1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163343-A1 | FRAGRANCE COMPOSITIONS FOR SLEEP IMPROVEMENT | INTERNATIONAL FLAVORES & FRAGRANCES INC. | 2025-05-22 | — | — | US | claimed |
| CN-119486703-A | Fragrance composition with lasting fragrance appearance | 弗门尼舍有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-11365370-B2 | Fragrance compositions | THE PROCTER & GAMBLE COMPANY (US) | 2022-06-21 | — | — | US | claimed |
| US-20200048578-A1 | ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2020-02-13 | — | — | US | claimed |
| US-9949911-B2 | Antiperspirant and deodorant compositions | THE PROCTER & GAMBLE COMPANY (US) | 2018-04-24 | — | — | US | claimed |
| US-20180051231-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2018-02-22 | — | — | US | claimed |
| EP-3271443-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2018-01-24 | — | — | EP | claimed |
| US-20170312204-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-11-02 | — | — | US | claimed |
| US-20170267944-A1 | FRAGRANCE COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-09-21 | — | — | US | claimed |
| EP-3139902-A2 | FRAGRANCE COMPOSITIONS | The Procter & Gamble Company (US) | 2017-03-15 | — | — | EP | claimed |
| WO-2016146673-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2016-09-22 | — | — | WO | claimed |
| US-20150322376-A1 | Fragrance Compositions | THE PROCTER & GAMBLE COMPANY | 2015-11-12 | — | — | US | claimed |
| WO-2015171738-A2 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2015-11-12 | — | — | WO | claimed |
| EP-2931234-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter and Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| EP-2931236-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| US-20140179722-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-26 | — | — | US | claimed |
| US-20140170194-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093819-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093747-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | LPO, GPX4, DEK | CYP2D6 287/4885HRH1 442/4885CHRM1 2662/4885 |
| US-20170312204-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | LPO, GPX4, DEK | CYP2D6 287/4885HRH1 442/4885CHRM1 2662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.